Stocks · Health care · Pharmaceutical Preparations

ACTUATE THERAPEUTICS, INC.

ACTU Clue Score35
United States Fiscal year ends December CIK 0001652935

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Leslie W. Kreis
14 Aug 2024
10% owner
Sold after exercise indirect
2,324
$9.00
$20.92K
Leslie W. Kreis
14 Aug 2024
10% owner
Sold after exercise indirect
17,361
$9.00
$156.25K
Leslie W. Kreis
14 Aug 2024
10% owner
Sold after exercise indirect
5,314
$9.00
$47.83K
Aaron G.L. Fletcher
14 Aug 2024
Director
Sold after exercise indirect
2,324
$9.00
$20.92K
Aaron G.L. Fletcher
14 Aug 2024
Director
Sold after exercise indirect
17,361
$9.00
$156.25K
Aaron G.L. Fletcher
14 Aug 2024
Director
Sold after exercise indirect
5,314
$9.00
$47.83K
Bios Equity COF, LP
14 Aug 2024
Director
Sold after exercise indirect
2,324
$9.00
$20.92K
Bios Equity COF, LP
14 Aug 2024
Director
Sold after exercise indirect
17,361
$9.00
$156.25K
Bios Equity COF, LP
14 Aug 2024
Director
Sold after exercise indirect
5,314
$9.00
$47.83K
Todd S Thomson
14 Aug 2024
Director
Sold after exercise indirect
18,750
$8.00
$150.00K

What was left out

Form 4 filings counted 42
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 10
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 31,648,232
History held since 14 Aug 2024